BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 18622238)

  • 1. Angiotensin receptor blockers improve insulin signaling and prevent microvascular rarefaction in the skeletal muscle of spontaneously hypertensive rats.
    Rizzoni D; Pasini E; Flati V; Rodella LF; Paiardi S; Assanelli D; De Ciuceis C; Porteri E; Boari GE; Rezzani R; Speca S; Favero G; Martinotti S; Toniato E; Platto C; Agabiti-Rosei E
    J Hypertens; 2008 Aug; 26(8):1595-601. PubMed ID: 18622238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats.
    Estato V; Obadia N; Carvalho-Tavares J; Freitas FS; Reis P; Castro-Faria Neto H; Lessa MA; Tibiriçá E
    Microvasc Res; 2013 May; 87():41-9. PubMed ID: 23466285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antihypertensive drugs on capillary rarefaction in spontaneously hypertensive rats: intravital microscopy and histologic analysis.
    Sabino B; Lessa MA; Nascimento AR; Rodrigues CA; Henriques Md; Garzoni LR; Levy BI; Tibiriçá E
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):402-9. PubMed ID: 18427284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of olmesartan and enalapril at low or high doses on cardiac, renal and vascular interstitial matrix in spontaneously hypertensive rats.
    Porteri E; Rodella L; Rizzoni D; Rezzani R; Paiardi S; Sleiman I; De Ciuceis C; Boari GE; Castellano M; Bianchi R; Agabiti-Rosei E
    Blood Press; 2005; 14(3):184-92. PubMed ID: 16036499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA; Rattan S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium channel blocker azelnidipine reduces glucose intolerance in diabetic mice via different mechanism than angiotensin receptor blocker olmesartan.
    Iwai M; Li HS; Chen R; Shiuchi T; Wu L; Min LJ; Li JM; Tsuda M; Suzuki J; Tomono Y; Tomochika H; Mogi M; Horiuchi M
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1081-7. PubMed ID: 16990512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olmesartan reduces oxidative stress in the brain of stroke-prone spontaneously hypertensive rats assessed by an in vivo ESR method.
    Araki S; Hirooka Y; Kishi T; Yasukawa K; Utsumi H; Sunagawa K
    Hypertens Res; 2009 Dec; 32(12):1091-6. PubMed ID: 19763130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models.
    Kusumoto K; Igata H; Ojima M; Tsuboi A; Imanishi M; Yamaguchi F; Sakamoto H; Kuroita T; Kawaguchi N; Nishigaki N; Nagaya H
    Eur J Pharmacol; 2011 Nov; 669(1-3):84-93. PubMed ID: 21816148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
    Agata J; Ura N; Yoshida H; Shinshi Y; Sasaki H; Hyakkoku M; Taniguchi S; Shimamoto K
    Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in endothelium-derived hyperpolarizing factor in hypertension and ageing: response to chronic treatment with renin-angiotensin system inhibitors.
    Goto K; Fujii K; Kansui Y; Iida M
    Clin Exp Pharmacol Physiol; 2004 Sep; 31(9):650-5. PubMed ID: 15479174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-angiotensin inhibition reverses advanced cardiac remodeling in aging spontaneously hypertensive rats.
    Ito N; Ohishi M; Yamamoto K; Tatara Y; Shiota A; Hayashi N; Komai N; Yanagitani Y; Rakugi H; Ogihara T
    Am J Hypertens; 2007 Jul; 20(7):792-9. PubMed ID: 17586415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AT(1) receptor blockers increase insulin-like growth factor-I production by stimulating sensory neurons in spontaneously hypertensive rats.
    Harada N; Shimozawa N; Okajima K
    Transl Res; 2009 Sep; 154(3):142-52. PubMed ID: 19665690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of the Renin-Angiotensin system improves insulin receptor signaling and insulin-stimulated skeletal muscle glucose transport in burn injury.
    Kasper SO; Phillips EE; Castle SM; Daley BJ; Enderson BL; Karlstad MD
    Shock; 2011 Jan; 35(1):80-5. PubMed ID: 20823693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of enalapril on the expression of cardiac angiotensin-converting enzyme and angiotensin-converting enzyme 2 in spontaneously hypertensive rats.
    Yang Z; Yu X; Cheng L; Miao LY; Li HX; Han LH; Jiang WP
    Arch Cardiovasc Dis; 2013 Apr; 106(4):196-201. PubMed ID: 23706365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of antihyperglycemic effects of moxonidine in the obese spontaneously hypertensive Koletsky rat (SHROB).
    Ernsberger P; Ishizuka T; Liu S; Farrell CJ; Bedol D; Koletsky RJ; Friedman JE
    J Pharmacol Exp Ther; 1999 Jan; 288(1):139-47. PubMed ID: 9862764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Pulse" treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertension.
    Ishiguro K; Hayashi K; Sasamura H; Sakamaki Y; Itoh H
    Hypertension; 2009 Jan; 53(1):83-9. PubMed ID: 19047581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of morphological changes in spontaneously hypertensive rats and normotensive Wistar Kyoto rats treated with an angiotensin-converting enzyme inhibitor or a calcium-channel blocker.
    Saleh FH; Jurjus AR
    J Pathol; 2001 Mar; 193(3):415-20. PubMed ID: 11241424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial responses in vitro and plasma digoxin immunoreactivity after losartan and enalapril treatments in experimental hypertension.
    Kalliovalkama J; Kähönen M; Tolvanen JP; Wu X; Voipio J; Pekki A; Doris PA; Ylitalo P; Pörsti I
    Pharmacol Toxicol; 2000 Jan; 86(1):36-43. PubMed ID: 10720105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
    Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular losartan (DuP 753)-sensitive angiotensin II receptor density is increased in young spontaneously hypertensive rats.
    Haws RM; Shaul PW; Arant BS; Atiyeh BA; Seikaly MG
    Pediatr Res; 1994 Jun; 35(6):671-6. PubMed ID: 7936816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.